# Trial to Determine the Safety and Efficacy of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold- Adapted (CAIV-T) in Healthy Children Attending Day Care Centers

> **NCT00192283** · PHASE3 · COMPLETED · sponsor: **MedImmune LLC** · enrollment: 2903 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** CAIV-T
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00192283
- **Lead sponsor:** MedImmune LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-09
- **Primary completion:** 2002-04
- **Final completion:** 2002-05
- **Target enrollment:** 2903 (ACTUAL)
- **Last updated:** 2009-04-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00192283

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00192283, "Trial to Determine the Safety and Efficacy of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold- Adapted (CAIV-T) in Healthy Children Attending Day Care Centers". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00192283. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*